Fish Oil and Lung Cancer: Can Omega-3 Fatty Acids Help During Treatment? Fish oil does not cure lung cancer. But omega-3 fatty acids—particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)—have been studied as supportive therapies for people undergoing lung cancer treatment.
The research is interesting because omega-3s may help address several problems that can accompany lung cancer and its treatment:
- Weight loss and cancer cachexia
- Loss of skeletal muscle
- Inflammation
- Poor nutritional status
- Treatment tolerance
- Possible response to chemotherapy
Some laboratory research also suggests that EPA and DHA can affect biological pathways involved in cancer-cell growth and death.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
David Emerson
Concepts Central to Managing Your Cancer-
Recommended Reading:
What Are EPA and DHA?
Fish oil contains long-chain omega-3 polyunsaturated fatty acids, principally:
- EPA — eicosapentaenoic acid
- DHA — docosahexaenoic acid
These fatty acids are found naturally in fatty fish such as salmon, sardines, herring, trout and mackerel and are also available as concentrated supplements.
Omega-3 fatty acids have been studied for their effects on inflammation, cardiovascular health, nutritional status and cancer-related metabolic changes.
For someone with lung cancer, the most interesting question isn’t whether fish oil is a replacement for conventional therapy—it isn’t.
The better question is:
Can omega-3 fatty acids complement conventional lung cancer treatment or help patients tolerate treatment and maintain their nutritional status?
The evidence suggests that this possibility deserves consideration.
Fish Oil and Chemotherapy Response in Non-Small Cell Lung Cancer
One of the most frequently cited studies was published in Cancer in 2011.
Researchers studied 46 patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy. Fifteen received fish oil providing approximately 2.5 grams of EPA plus DHA per day, while 31 received standard care without fish-oil supplementation.
The results were provocative.
The researchers reported a chemotherapy response rate of:
60% in the fish-oil group
versus
25.8% in the standard-care group.
Clinical benefit—complete response, partial response, or stable disease—was also higher:
80% versus 41.9%.
Importantly, dose-limiting toxicity was not significantly different between the groups.
One-year survival was numerically higher among patients receiving fish oil (60% versus 38.7%), but this difference was not statistically significant.
Read the study on PubMed
What this study does—and doesn’t—tell us
This is intriguing evidence, but it should not be overstated.
The study was small, and only 15 patients completed treatment in the fish-oil group. It also involved chemotherapy regimens used at that time. Lung cancer treatment has changed enormously since 2011 with the development of targeted therapies and immune checkpoint inhibitors.
Therefore, this study cannot establish that fish oil improves survival or makes today’s lung cancer therapies more effective.
It does provide a reasonable scientific basis for further investigation.
Omega-3s May Help Maintain Weight and Nutritional Status
For many patients, the more compelling argument for omega-3 fatty acids involves nutrition rather than directly killing cancer.
Weight loss and loss of muscle mass can become serious problems in people with lung cancer.
In a randomized study involving patients with stage III NSCLC receiving multimodality treatment, researchers investigated a protein- and energy-dense nutritional supplement containing approximately:
- 2 grams EPA daily
- 0.9 grams DHA daily
The researchers found evidence that the omega-3-containing nutritional intervention helped support aspects of nutritional status during treatment.
Read the study on PubMed
Another randomized, double-blind study examined EPA and DHA supplementation in patients with advanced inoperable NSCLC receiving chemotherapy and investigated changes in inflammation, oxidative stress and nutritional status.
Read the study on PubMed
These studies are small, but collectively they point toward an important potential role for omega-3 fatty acids:
helping some patients maintain nutritional and metabolic health during cancer treatment.
What Does the Larger Body of Research Show?
A 2022 meta-analysis examined seven randomized controlled trials of omega-3 fatty acids in lung cancer patients undergoing chemotherapy and/or radiation therapy.
The analysis found that omega-3 supplementation was associated with improvements in several measures of nutritional status, including body weight and albumin, as well as reductions in inflammatory markers including C-reactive protein (CRP) and TNF-alpha.
However, improvements in energy and protein intake were not statistically significant.
The authors concluded that omega-3 fatty acids may improve nutritional status and inflammatory measures in lung cancer patients receiving treatment.
Read the meta-analysis on PubMed
This is considerably stronger evidence for supportive nutritional use than for treating the cancer itself.
What About Cancer Cachexia?
Cancer cachexia is much more complicated than simply not eating enough.
It is a metabolic syndrome involving involuntary weight loss, muscle loss, inflammation and changes in metabolism. Advanced lung cancer is one of the cancers commonly associated with cachexia.
Omega-3 fatty acids—especially EPA—have been studied extensively for this problem.
But the evidence is mixed.
An earlier Cochrane review of randomized trials concluded that there was insufficient evidence to establish that EPA alone was superior to placebo for cancer cachexia.
Read the review on PubMed
That finding is important because it prevents us from turning a promising nutritional therapy into an unsupported claim.
The best interpretation is that omega-3s may be one component of nutritional support, rather than a stand-alone treatment for cachexia.
Current clinical nutrition guidance likewise emphasizes comprehensive nutritional assessment and individualized nutrition intervention for people with cancer.
ESPEN Practical Guideline: Clinical Nutrition in Cancer
Can Fish Oil Kill Lung Cancer Cells?
Laboratory evidence is another reason fish oil has attracted interest in cancer research.
EPA and DHA can become incorporated into cell membranes and influence inflammatory signaling, lipid metabolism, oxidative stress and several pathways associated with cell survival and cell death.
Earlier laboratory studies found that omega-3 fatty acids could inhibit proliferation or induce apoptosis in several lung cancer cell lines.
This research helps explain why scientists continue studying omega-3 fatty acids in cancer.
But laboratory research needs to be interpreted carefully.
Killing lung cancer cells in a petri dish is not equivalent to shrinking a tumor in a human being.
This is one of the most important evidence distinctions we make at PeopleBeatingCancer.
Does Fish Oil Cure Lung Cancer?
No evidence currently demonstrates that fish oil cures lung cancer.
Patients should therefore not use fish oil instead of established treatments such as:
- Surgery
- Radiation therapy
- Chemotherapy
- Targeted therapy
- Immunotherapy
Treatment depends on the type and stage of lung cancer as well as tumor biomarkers and the patient’s overall health.
Omega-3 supplementation belongs in the category of potential complementary/supportive therapy, not alternative curative therapy.
PeopleBeatingCancer Evidence Rating
| Claim |
Evidence |
PBC Rating |
| Fish oil cures lung cancer |
No convincing human clinical evidence |
Insufficient / Not supported |
| EPA/DHA can affect lung cancer cells |
Preclinical laboratory evidence |
Promising preclinical evidence |
| Omega-3s may support nutritional status during lung cancer treatment |
Randomized trials + meta-analysis |
Moderate evidence |
| Omega-3s may reduce inflammatory markers during treatment |
Clinical trials + meta-analysis |
Moderate evidence |
| Fish oil improves chemotherapy response |
Small human study |
Preliminary clinical evidence |
| Fish oil improves lung cancer survival |
Insufficient clinical evidence |
Unproven |
| Omega-3s may help prevent treatment-related weight/muscle loss |
Mixed clinical evidence |
Promising but inconsistent |
PBC interpretation
The strongest case for omega-3 fatty acids in lung cancer is currently supportive care and nutrition, not direct cancer treatment.
The chemotherapy-response research is intriguing but requires larger modern randomized trials before firm conclusions can be made.
How Much Fish Oil?
This is where patients should be cautious about translating clinical trials directly into self-treatment.
Clinical studies have used different amounts and formulations of EPA and DHA. Some lung cancer studies have used roughly 2–3 grams per day of combined EPA/DHA, which can be considerably more than the amount contained in a typical over-the-counter fish-oil capsule.
More is not necessarily better.
The NIH Office of Dietary Supplements notes that omega-3 supplements can cause gastrointestinal symptoms and that high doses can affect platelet function and potentially interact with anticoagulant medications.
NIH Office of Dietary Supplements: Omega-3 Fatty Acids
Cancer patients should therefore discuss supplemental EPA/DHA with their oncologist, oncology pharmacist or oncology dietitian—particularly if they:
- Take anticoagulants or antiplatelet medications
- Have a bleeding disorder
- Are preparing for surgery
- Take multiple supplements
- Have cardiovascular disease or arrhythmias
- Are receiving chemotherapy, targeted therapy or immunotherapy
Food First Is Still a Reasonable Strategy
Omega-3 fatty acids don’t have to come from supplements.
Fatty fish provide EPA and DHA along with protein and other nutrients important during cancer treatment.
Examples include:
- Salmon
- Sardines
- Trout
- Herring
- Mackerel
For patients struggling with appetite, weight loss or muscle loss, however, nutritional requirements may be very different. An oncology dietitian can help determine whether food alone is sufficient or whether an omega-3-enriched nutritional supplement makes sense.
Related PeopleBeatingCancer Resources
If you are researching nutrition and complementary therapies for lung cancer, see:
The Bottom Line
Fish oil is not a cure for lung cancer.
EPA and DHA have demonstrated biological activity against lung cancer cells in laboratory studies. Small clinical studies suggest possible benefits involving chemotherapy response, nutritional status, inflammation, and preservation of body weight or muscle. A meta-analysis of randomized trials also supports potential nutritional and anti-inflammatory benefits during lung cancer treatment.
For me, that makes omega-3 fatty acids an example of what PeopleBeatingCancer is trying to evaluate: an inexpensive, readily available complementary therapy with legitimate scientific evidence behind it—but evidence that must be presented at the level the research actually supports.
“While a large body of evidence indicates that n-6 polyunsaturated fatty acids promote the growth of tumor cells, n-3 fatty acids (e.g. EPA and DHA) have actually been shown to inhibit breast, colon, prostate, and lung tumor cell proliferation (Reviews in [13,14]). EPA and DHA have also been shown to induce apoptosis in a number of cell lines, including human lung A549 and A427 cells (15–17). Fish oil inhibited the growth of NSCLC cell lines (H1838 and H1792) by suppressing integrin-linked kinases (18)…”
“New research has revealed that daily doses of fish oil for lung cancer patients improve the efficiency of chemotherapy, may contribute to increased survival and help prevent muscle and weight loss that commonly occurs…”